- About Us
- Studies for Risk Management
- Consulting on Risk Management
- Other Research Services
- Public Health
- Study Recruitment
The Drug Safety Research Unit (DSRU) is an independent academic unit internationally respected for its work in Pharmacovigilance, Pharmacoepidemiology, Risk Management and Training for over 30 years.
In partnership with doctors in England, the DSRU, led by Director Professor Saad Shakir, aims to protect patients in primary and specialist care from unwanted adverse effects of newly marketed medicines using our unique methods of monitoring patients during the lifecycle of medicines.
The ROSE study made Study of the Month in the NIHR Clinical Research Network's "speciality groups" newsletter only 6 months after it opened. This was a great forum to highlight the excellent recruitment progress within the trusts and a fantastic start to the study. The ROSE study was initially adopted by the Non-malignant Haematology and Cardiovascular Specialty Groups with co-support provided by Stroke Research Network.
Recruitment enters its second year in September with more study sites due to open and active sites maintaining their commitment to the study. We aim to forge links with the emerging relevant speciality groups and the clinical leads who regularly review study progress, ensure that barriers to recruitment are resolved and the right support is in place to deliver all studies successfully in the NHS.
Further information about the ROSE study is available here.View our latest news